Document Detail


Beta-blocker therapy and primary angioplasty: what is the controversy?
MedLine Citation:
PMID:  15145100     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
David P Faxon
Publication Detail:
Type:  Comment; Editorial    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  43     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2004 May 
Date Detail:
Created Date:  2004-05-17     Completed Date:  2004-06-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1788-90     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Angioplasty, Transluminal, Percutaneous Coronary / methods*
Humans
Myocardial Infarction / drug therapy,  therapy*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists
Comments/Corrections
Comment On:
J Am Coll Cardiol. 2004 May 19;43(10):1780-7   [PMID:  15145099 ]
J Am Coll Cardiol. 2004 May 19;43(10):1773-9   [PMID:  15145098 ]
J Am Coll Cardiol. 2004 May 19;43(10):1765-72   [PMID:  15145097 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing me...
Next Document:  The distribution of 10-Year risk for coronary heart disease among US adults: findings from the Natio...